NCAM1 and B-cell chronic lymphocytic leukemia: Given the prognostic role of immunophenotypic markers in CLL patients, the aim of study was to assess the association between expression of CD38, CD25, and double-positive CD56 and CD117 (ILC3s) markers with peripheral complete blood cell count (CBC) values in CLL patients, and staging as defined by different schemes and clinical parameters.